HEADER APOPTOSIS 12-APR-12 4AQ3 TITLE HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: RESIDUES 1-33 AND 92-207 OF P10415 AND RESIDUES 29-44 OF COMPND 5 Q07817; COMPND 6 SYNONYM: BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: APOPTOSIS REGULATOR BCL-2 WITH PUTATIVE FLEXIBLE COMPND 9 LOOP REPLACED WITH A PORTION OF APOPTOSIS REGULATOR BCL-X PROTEIN SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS APOPTOSIS, CHIMERA EXPDTA X-RAY DIFFRACTION AUTHOR J.A.BERTRAND,M.FASOLINI,M.MODUGNO REVDAT 2 21-NOV-12 4AQ3 1 SEQADV REVDAT 1 06-JUN-12 4AQ3 0 JRNL AUTH H.L.PEREZ,P.BANFI,J.A.BERTRAND,Z.W.CAI,J.W.GREBINSKI,K.KIM, JRNL AUTH 2 J.LIPPY,M.MODUGNO,J.NAGLICH,R.J.SCHMIDT,A.TEBBEN,P.VIANELLO, JRNL AUTH 3 D.D.WEI,L.ZHANG,A.GALVANI,L.J.LOMBARDO,R.M.BORZILLERI JRNL TITL IDENTIFICATION OF A PHENYLACYLSULFONAMIDE SERIES OF DUAL JRNL TITL 2 BCL-2/BCL-XL ANTAGONISTS. JRNL REF BIOORG.MED.CHEM.LETT. V. 22 3946 2012 JRNL REFN ISSN 0960-894X JRNL PMID 22608961 JRNL DOI 10.1016/J.BMCL.2012.04.103 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 100.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 97.75 REMARK 3 NUMBER OF REFLECTIONS : 55094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.20300 REMARK 3 R VALUE (WORKING SET) : 0.20072 REMARK 3 FREE R VALUE : 0.24494 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2926 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.400 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.462 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3637 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.19 REMARK 3 BIN R VALUE (WORKING SET) : 0.317 REMARK 3 BIN FREE R VALUE SET COUNT : 174 REMARK 3 BIN FREE R VALUE : 0.409 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6778 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 318 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.235 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.31 REMARK 3 B22 (A**2) : 0.31 REMARK 3 B33 (A**2) : -0.46 REMARK 3 B12 (A**2) : 0.15 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.255 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.216 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.161 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.963 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7311 ; 0.013 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9916 ; 1.884 ; 1.961 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 802 ; 6.870 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 403 ;35.705 ;22.581 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1108 ;19.747 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 72 ;22.373 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 952 ; 0.111 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5854 ; 0.011 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B C D E F REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 2 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 10 A 30 4 REMARK 3 1 B 10 B 30 4 REMARK 3 1 C 10 C 30 4 REMARK 3 1 D 10 D 30 4 REMARK 3 1 E 10 E 30 4 REMARK 3 1 F 10 F 30 4 REMARK 3 2 A 52 A 157 4 REMARK 3 2 B 52 B 157 4 REMARK 3 2 C 52 C 157 4 REMARK 3 2 D 52 D 157 4 REMARK 3 2 E 52 E 157 4 REMARK 3 2 F 52 F 157 4 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1059 ; 0.32 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 B (A): 1059 ; 0.27 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 C (A): 1059 ; 0.35 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 D (A): 1059 ; 0.32 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 E (A): 1059 ; 0.34 ; 0.50 REMARK 3 MEDIUM POSITIONAL 1 F (A): 1059 ; 0.34 ; 0.50 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1059 ; 5.65 ; 2.00 REMARK 3 MEDIUM THERMAL 1 B (A**2): 1059 ; 4.56 ; 2.00 REMARK 3 MEDIUM THERMAL 1 C (A**2): 1059 ; 5.89 ; 2.00 REMARK 3 MEDIUM THERMAL 1 D (A**2): 1059 ; 5.63 ; 2.00 REMARK 3 MEDIUM THERMAL 1 E (A**2): 1059 ; 6.70 ; 2.00 REMARK 3 MEDIUM THERMAL 1 F (A**2): 1059 ; 6.01 ; 2.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -2 A 166 REMARK 3 ORIGIN FOR THE GROUP (A): -13.8902 14.2160 -10.2099 REMARK 3 T TENSOR REMARK 3 T11: 0.0879 T22: 0.0672 REMARK 3 T33: 0.0304 T12: 0.0178 REMARK 3 T13: 0.0018 T23: -0.0228 REMARK 3 L TENSOR REMARK 3 L11: 2.2077 L22: 1.5279 REMARK 3 L33: 1.2490 L12: -0.2539 REMARK 3 L13: 0.5596 L23: 0.1709 REMARK 3 S TENSOR REMARK 3 S11: -0.0469 S12: -0.0035 S13: 0.1670 REMARK 3 S21: -0.0266 S22: -0.0463 S23: 0.0156 REMARK 3 S31: -0.0903 S32: 0.0446 S33: 0.0932 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B -2 B 166 REMARK 3 ORIGIN FOR THE GROUP (A): -42.2120 17.9809 -44.6444 REMARK 3 T TENSOR REMARK 3 T11: 0.0952 T22: 0.0497 REMARK 3 T33: 0.0425 T12: 0.0392 REMARK 3 T13: 0.0241 T23: 0.0316 REMARK 3 L TENSOR REMARK 3 L11: 2.1553 L22: 1.3696 REMARK 3 L33: 1.4854 L12: -0.5062 REMARK 3 L13: -0.3255 L23: 0.4285 REMARK 3 S TENSOR REMARK 3 S11: -0.0857 S12: 0.0387 S13: -0.0572 REMARK 3 S21: 0.1530 S22: 0.0795 S23: -0.0099 REMARK 3 S31: 0.0978 S32: 0.0241 S33: 0.0062 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : C -2 C 166 REMARK 3 ORIGIN FOR THE GROUP (A): -7.4064 -21.1416 -11.6370 REMARK 3 T TENSOR REMARK 3 T11: 0.0892 T22: 0.0697 REMARK 3 T33: 0.0204 T12: -0.0171 REMARK 3 T13: 0.0052 T23: -0.0071 REMARK 3 L TENSOR REMARK 3 L11: 0.6481 L22: 3.1235 REMARK 3 L33: 1.5524 L12: 0.0372 REMARK 3 L13: -0.0388 L23: 0.5744 REMARK 3 S TENSOR REMARK 3 S11: 0.1068 S12: 0.0135 S13: -0.0601 REMARK 3 S21: -0.0108 S22: -0.1555 S23: 0.1084 REMARK 3 S31: 0.0810 S32: -0.1644 S33: 0.0487 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : D -2 D 166 REMARK 3 ORIGIN FOR THE GROUP (A): -10.3502 16.4464 -44.0337 REMARK 3 T TENSOR REMARK 3 T11: 0.0482 T22: 0.0678 REMARK 3 T33: 0.1338 T12: -0.0170 REMARK 3 T13: -0.0565 T23: 0.0405 REMARK 3 L TENSOR REMARK 3 L11: 3.3229 L22: 1.5146 REMARK 3 L33: 2.2469 L12: -1.5719 REMARK 3 L13: 0.5386 L23: -0.0427 REMARK 3 S TENSOR REMARK 3 S11: -0.1976 S12: 0.3195 S13: 0.3311 REMARK 3 S21: 0.0809 S22: -0.0081 S23: 0.0013 REMARK 3 S31: -0.1798 S32: 0.1513 S33: 0.2057 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E -2 E 166 REMARK 3 ORIGIN FOR THE GROUP (A): -45.9430 15.6412 -9.4843 REMARK 3 T TENSOR REMARK 3 T11: 0.0503 T22: 0.0458 REMARK 3 T33: 0.0997 T12: 0.0004 REMARK 3 T13: 0.0182 T23: 0.0426 REMARK 3 L TENSOR REMARK 3 L11: 4.7431 L22: 1.7409 REMARK 3 L33: 1.5761 L12: -1.4547 REMARK 3 L13: -0.6513 L23: 0.5865 REMARK 3 S TENSOR REMARK 3 S11: -0.2777 S12: 0.1166 S13: -0.3711 REMARK 3 S21: -0.0197 S22: 0.1402 S23: 0.3679 REMARK 3 S31: 0.0917 S32: 0.0948 S33: 0.1375 REMARK 3 REMARK 3 TLS GROUP : 6 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F -2 F 166 REMARK 3 ORIGIN FOR THE GROUP (A): -50.3924 50.2935 -8.9127 REMARK 3 T TENSOR REMARK 3 T11: 0.0554 T22: 0.0534 REMARK 3 T33: 0.0843 T12: -0.0098 REMARK 3 T13: -0.0019 T23: 0.0471 REMARK 3 L TENSOR REMARK 3 L11: 1.5204 L22: 2.2972 REMARK 3 L33: 1.2614 L12: -0.6744 REMARK 3 L13: 0.5222 L23: 0.1825 REMARK 3 S TENSOR REMARK 3 S11: 0.1009 S12: 0.1569 S13: 0.1134 REMARK 3 S21: -0.1511 S22: -0.1342 S23: -0.1282 REMARK 3 S31: -0.0221 S32: 0.1521 S33: 0.0333 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4AQ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-APR-12. REMARK 100 THE PDBE ID CODE IS EBI-52041. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07200 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD (QUANTUM 315) REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58071 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.40 REMARK 200 RESOLUTION RANGE LOW (A) : 40.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 200 DATA REDUNDANCY : 3.4 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.20 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.7 REMARK 200 R MERGE FOR SHELL (I) : 0.58 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: INTERNAL STRUCTURE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.3 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.21200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 34.10600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 ALA A 4 REMARK 465 GLY A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 GLY A 8 REMARK 465 ALA A 32 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 ASP A 35 REMARK 465 VAL A 36 REMARK 465 GLU A 37 REMARK 465 GLU A 38 REMARK 465 ASN A 39 REMARK 465 ARG A 40 REMARK 465 THR A 41 REMARK 465 GLU A 42 REMARK 465 ALA A 43 REMARK 465 PRO A 44 REMARK 465 GLU A 45 REMARK 465 GLY A 46 REMARK 465 THR A 47 REMARK 465 GLU A 48 REMARK 465 SER A 49 REMARK 465 GLU A 50 REMARK 465 PRO A 163 REMARK 465 SER A 164 REMARK 465 MET A 165 REMARK 465 ARG A 166 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 HIS B 3 REMARK 465 ALA B 4 REMARK 465 GLY B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 GLY B 8 REMARK 465 ALA B 32 REMARK 465 GLY B 33 REMARK 465 ASP B 34 REMARK 465 ASP B 35 REMARK 465 VAL B 36 REMARK 465 GLU B 37 REMARK 465 GLU B 38 REMARK 465 ASN B 39 REMARK 465 ARG B 40 REMARK 465 THR B 41 REMARK 465 GLU B 42 REMARK 465 ALA B 43 REMARK 465 PRO B 44 REMARK 465 GLU B 45 REMARK 465 GLY B 46 REMARK 465 THR B 47 REMARK 465 GLU B 48 REMARK 465 SER B 49 REMARK 465 GLU B 50 REMARK 465 PRO B 163 REMARK 465 SER B 164 REMARK 465 MET B 165 REMARK 465 ARG B 166 REMARK 465 GLY C -2 REMARK 465 SER C -1 REMARK 465 HIS C 0 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 HIS C 3 REMARK 465 ALA C 4 REMARK 465 GLY C 5 REMARK 465 ARG C 6 REMARK 465 THR C 7 REMARK 465 GLY C 8 REMARK 465 ALA C 32 REMARK 465 GLY C 33 REMARK 465 ASP C 34 REMARK 465 ASP C 35 REMARK 465 VAL C 36 REMARK 465 GLU C 37 REMARK 465 GLU C 38 REMARK 465 ASN C 39 REMARK 465 ARG C 40 REMARK 465 THR C 41 REMARK 465 GLU C 42 REMARK 465 ALA C 43 REMARK 465 PRO C 44 REMARK 465 GLU C 45 REMARK 465 GLY C 46 REMARK 465 THR C 47 REMARK 465 GLU C 48 REMARK 465 SER C 49 REMARK 465 GLU C 50 REMARK 465 PRO C 163 REMARK 465 SER C 164 REMARK 465 MET C 165 REMARK 465 ARG C 166 REMARK 465 GLY D -2 REMARK 465 SER D -1 REMARK 465 HIS D 0 REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 HIS D 3 REMARK 465 ALA D 4 REMARK 465 GLY D 5 REMARK 465 ARG D 6 REMARK 465 THR D 7 REMARK 465 GLY D 8 REMARK 465 ALA D 32 REMARK 465 GLY D 33 REMARK 465 ASP D 34 REMARK 465 ASP D 35 REMARK 465 VAL D 36 REMARK 465 GLU D 37 REMARK 465 GLU D 38 REMARK 465 ASN D 39 REMARK 465 ARG D 40 REMARK 465 THR D 41 REMARK 465 GLU D 42 REMARK 465 ALA D 43 REMARK 465 PRO D 44 REMARK 465 GLU D 45 REMARK 465 GLY D 46 REMARK 465 THR D 47 REMARK 465 GLU D 48 REMARK 465 PRO D 163 REMARK 465 SER D 164 REMARK 465 MET D 165 REMARK 465 ARG D 166 REMARK 465 GLY E -2 REMARK 465 SER E -1 REMARK 465 HIS E 0 REMARK 465 MET E 1 REMARK 465 ALA E 2 REMARK 465 HIS E 3 REMARK 465 ALA E 4 REMARK 465 GLY E 5 REMARK 465 ARG E 6 REMARK 465 THR E 7 REMARK 465 GLY E 8 REMARK 465 TYR E 9 REMARK 465 GLY E 33 REMARK 465 ASP E 34 REMARK 465 ASP E 35 REMARK 465 VAL E 36 REMARK 465 GLU E 37 REMARK 465 GLU E 38 REMARK 465 ASN E 39 REMARK 465 ARG E 40 REMARK 465 THR E 41 REMARK 465 GLU E 42 REMARK 465 ALA E 43 REMARK 465 PRO E 44 REMARK 465 GLU E 45 REMARK 465 GLY E 46 REMARK 465 THR E 47 REMARK 465 GLU E 48 REMARK 465 SER E 49 REMARK 465 GLU E 50 REMARK 465 PRO E 163 REMARK 465 SER E 164 REMARK 465 MET E 165 REMARK 465 ARG E 166 REMARK 465 GLY F -2 REMARK 465 SER F -1 REMARK 465 HIS F 0 REMARK 465 MET F 1 REMARK 465 ALA F 2 REMARK 465 HIS F 3 REMARK 465 ALA F 4 REMARK 465 GLY F 5 REMARK 465 ARG F 6 REMARK 465 THR F 7 REMARK 465 GLY F 8 REMARK 465 GLY F 33 REMARK 465 ASP F 34 REMARK 465 ASP F 35 REMARK 465 VAL F 36 REMARK 465 GLU F 37 REMARK 465 GLU F 38 REMARK 465 ASN F 39 REMARK 465 ARG F 40 REMARK 465 THR F 41 REMARK 465 GLU F 42 REMARK 465 ALA F 43 REMARK 465 PRO F 44 REMARK 465 GLU F 45 REMARK 465 GLY F 46 REMARK 465 THR F 47 REMARK 465 GLU F 48 REMARK 465 SER F 49 REMARK 465 PRO F 163 REMARK 465 SER F 164 REMARK 465 MET F 165 REMARK 465 ARG F 166 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 18 OE2 GLU A 111 2.13 REMARK 500 OE1 GLU A 94 NH2 ARG A 98 2.17 REMARK 500 OH TYR C 9 OD1 ASP C 155 2.09 REMARK 500 OH TYR C 18 OE2 GLU C 111 1.94 REMARK 500 OH TYR D 18 OE2 GLU D 111 2.18 REMARK 500 OH TYR E 18 OE2 GLU E 111 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TRP A 147 CD2 TRP A 147 CE2 0.073 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG C 66 NE - CZ - NH2 ANGL. DEV. = 3.2 DEGREES REMARK 500 ASP D 61 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 159 27.14 -66.75 REMARK 500 LEU A 160 -63.50 -121.11 REMARK 500 GLN B 25 -42.56 -27.51 REMARK 500 GLN C 25 -38.39 -33.03 REMARK 500 GLU D 50 -47.94 68.94 REMARK 500 TYR D 161 -164.24 103.64 REMARK 500 HIS E 79 71.18 36.33 REMARK 500 ASP F 31 89.14 -63.24 REMARK 500 ASP F 99 24.38 -79.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TYR D 9 ASP D 10 143.78 REMARK 500 TYR F 9 ASP F 10 -144.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 398 A1163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 398 B1163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 398 C1163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 398 D1163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 398 E1163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 398 F1163 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BXL RELATED DB: PDB REMARK 900 STRUCTURE OF BCL-XL/BAK PEPTIDE COMPLEX, NMR, REMARK 900 MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1G5J RELATED DB: PDB REMARK 900 COMPLEX OF BCL-XL WITH PEPTIDE FROM BAD REMARK 900 RELATED ID: 1G5M RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 1 REMARK 900 RELATED ID: 1GJH RELATED DB: PDB REMARK 900 HUMAN BCL-2, ISOFORM 2 REMARK 900 RELATED ID: 1LXL RELATED DB: PDB REMARK 900 NMR STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED REMARK 900 CELL DEATH, MINIMIZED AVERAGE STRUCTURE REMARK 900 RELATED ID: 1MAZ RELATED DB: PDB REMARK 900 X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF REMARK 900 PROGRAMMED CELL DEATH REMARK 900 RELATED ID: 1R2D RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS REMARK 900 RELATED ID: 1R2E RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT REMARK 900 POSITION 92 REMARK 900 RELATED ID: 1R2G RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT REMARK 900 POSITION 97 REMARK 900 RELATED ID: 1R2H RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT REMARK 900 POSITION142 REMARK 900 RELATED ID: 1R2I RELATED DB: PDB REMARK 900 HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT REMARK 900 POSITION146 REMARK 900 RELATED ID: 1YSG RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- REMARK 900 XL INCOMPLEX WITH "SAR BY NMR" LIGANDS REMARK 900 RELATED ID: 1YSI RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- REMARK 900 XL INCOMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 1YSN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- REMARK 900 XLCOMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 1YSW RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL- REMARK 900 2COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND REMARK 900 RELATED ID: 2B48 RELATED DB: PDB REMARK 900 BCL-XL 3D DOMAIN SWAPPED DIMER REMARK 900 RELATED ID: 2W3L RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHIMAERIC BCL2-XL AND PHENYL REMARK 900 TETRAHYDROISOQUINOLINE AMIDE COMPLEX REMARK 900 RELATED ID: 2XA0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BCL-2 IN COMPLEX WITH A BAX REMARK 900 BH3 PEPTIDE REMARK 900 RELATED ID: 2YJ1 RELATED DB: PDB REMARK 900 PUMA BH3 FOLDAMER IN COMPLEX WITH BCL-XL REMARK 900 RELATED ID: 4A1U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALPHA-BETA-FOLDAMER 2C IN COMPLEX REMARK 900 WITH BCL-XL REMARK 900 RELATED ID: 4A1W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALPHA-BETA FOLDAMER 4C IN COMPLEX REMARK 900 WITH BCL-XL DBREF 4AQ3 A 1 33 UNP P10415 BCL2_HUMAN 1 33 DBREF 4AQ3 A 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 4AQ3 A 51 166 UNP P10415 BCL2_HUMAN 92 207 DBREF 4AQ3 B 1 33 UNP P10415 BCL2_HUMAN 1 33 DBREF 4AQ3 B 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 4AQ3 B 51 166 UNP P10415 BCL2_HUMAN 92 207 DBREF 4AQ3 C 1 33 UNP P10415 BCL2_HUMAN 1 33 DBREF 4AQ3 C 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 4AQ3 C 51 166 UNP P10415 BCL2_HUMAN 92 207 DBREF 4AQ3 D 1 33 UNP P10415 BCL2_HUMAN 1 33 DBREF 4AQ3 D 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 4AQ3 D 51 166 UNP P10415 BCL2_HUMAN 92 207 DBREF 4AQ3 E 1 33 UNP P10415 BCL2_HUMAN 1 33 DBREF 4AQ3 E 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 4AQ3 E 51 166 UNP P10415 BCL2_HUMAN 92 207 DBREF 4AQ3 F 1 33 UNP P10415 BCL2_HUMAN 1 33 DBREF 4AQ3 F 35 50 UNP Q07817 BCLX_HUMAN 29 44 DBREF 4AQ3 F 51 166 UNP P10415 BCL2_HUMAN 92 207 SEQADV 4AQ3 GLY A -2 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 SER A -1 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 HIS A 0 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ASP A 34 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ALA A 55 UNP P10415 THR 96 VARIANT SEQADV 4AQ3 GLY A 69 UNP P10415 ARG 110 VARIANT SEQADV 4AQ3 GLY B -2 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 SER B -1 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 HIS B 0 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ASP B 34 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ALA B 55 UNP P10415 THR 96 VARIANT SEQADV 4AQ3 GLY B 69 UNP P10415 ARG 110 VARIANT SEQADV 4AQ3 GLY C -2 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 SER C -1 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 HIS C 0 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ASP C 34 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ALA C 55 UNP P10415 THR 96 VARIANT SEQADV 4AQ3 GLY C 69 UNP P10415 ARG 110 VARIANT SEQADV 4AQ3 GLY D -2 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 SER D -1 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 HIS D 0 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ASP D 34 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ALA D 55 UNP P10415 THR 96 VARIANT SEQADV 4AQ3 GLY D 69 UNP P10415 ARG 110 VARIANT SEQADV 4AQ3 GLY E -2 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 SER E -1 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 HIS E 0 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ASP E 34 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ALA E 55 UNP P10415 THR 96 VARIANT SEQADV 4AQ3 GLY E 69 UNP P10415 ARG 110 VARIANT SEQADV 4AQ3 GLY F -2 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 SER F -1 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 HIS F 0 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ASP F 34 UNP P10415 EXPRESSION TAG SEQADV 4AQ3 ALA F 55 UNP P10415 THR 96 VARIANT SEQADV 4AQ3 GLY F 69 UNP P10415 ARG 110 VARIANT SEQRES 1 A 169 GLY SER HIS MET ALA HIS ALA GLY ARG THR GLY TYR ASP SEQRES 2 A 169 ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SEQRES 3 A 169 SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL SEQRES 4 A 169 GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SER SEQRES 5 A 169 GLU VAL VAL HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP SEQRES 6 A 169 PHE SER ARG ARG TYR ARG GLY ASP PHE ALA GLU MET SER SEQRES 7 A 169 SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG SEQRES 8 A 169 PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL SEQRES 9 A 169 ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY SEQRES 10 A 169 VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO SEQRES 11 A 169 LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU SEQRES 12 A 169 ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY SEQRES 13 A 169 TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 B 169 GLY SER HIS MET ALA HIS ALA GLY ARG THR GLY TYR ASP SEQRES 2 B 169 ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SEQRES 3 B 169 SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL SEQRES 4 B 169 GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SER SEQRES 5 B 169 GLU VAL VAL HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP SEQRES 6 B 169 PHE SER ARG ARG TYR ARG GLY ASP PHE ALA GLU MET SER SEQRES 7 B 169 SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG SEQRES 8 B 169 PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL SEQRES 9 B 169 ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY SEQRES 10 B 169 VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO SEQRES 11 B 169 LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU SEQRES 12 B 169 ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY SEQRES 13 B 169 TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 C 169 GLY SER HIS MET ALA HIS ALA GLY ARG THR GLY TYR ASP SEQRES 2 C 169 ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SEQRES 3 C 169 SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL SEQRES 4 C 169 GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SER SEQRES 5 C 169 GLU VAL VAL HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP SEQRES 6 C 169 PHE SER ARG ARG TYR ARG GLY ASP PHE ALA GLU MET SER SEQRES 7 C 169 SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG SEQRES 8 C 169 PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL SEQRES 9 C 169 ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY SEQRES 10 C 169 VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO SEQRES 11 C 169 LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU SEQRES 12 C 169 ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY SEQRES 13 C 169 TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 D 169 GLY SER HIS MET ALA HIS ALA GLY ARG THR GLY TYR ASP SEQRES 2 D 169 ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SEQRES 3 D 169 SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL SEQRES 4 D 169 GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SER SEQRES 5 D 169 GLU VAL VAL HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP SEQRES 6 D 169 PHE SER ARG ARG TYR ARG GLY ASP PHE ALA GLU MET SER SEQRES 7 D 169 SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG SEQRES 8 D 169 PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL SEQRES 9 D 169 ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY SEQRES 10 D 169 VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO SEQRES 11 D 169 LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU SEQRES 12 D 169 ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY SEQRES 13 D 169 TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 E 169 GLY SER HIS MET ALA HIS ALA GLY ARG THR GLY TYR ASP SEQRES 2 E 169 ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SEQRES 3 E 169 SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL SEQRES 4 E 169 GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SER SEQRES 5 E 169 GLU VAL VAL HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP SEQRES 6 E 169 PHE SER ARG ARG TYR ARG GLY ASP PHE ALA GLU MET SER SEQRES 7 E 169 SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG SEQRES 8 E 169 PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL SEQRES 9 E 169 ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY SEQRES 10 E 169 VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO SEQRES 11 E 169 LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU SEQRES 12 E 169 ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY SEQRES 13 E 169 TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 F 169 GLY SER HIS MET ALA HIS ALA GLY ARG THR GLY TYR ASP SEQRES 2 F 169 ASN ARG GLU ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SEQRES 3 F 169 SER GLN ARG GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL SEQRES 4 F 169 GLU GLU ASN ARG THR GLU ALA PRO GLU GLY THR GLU SER SEQRES 5 F 169 GLU VAL VAL HIS LEU ALA LEU ARG GLN ALA GLY ASP ASP SEQRES 6 F 169 PHE SER ARG ARG TYR ARG GLY ASP PHE ALA GLU MET SER SEQRES 7 F 169 SER GLN LEU HIS LEU THR PRO PHE THR ALA ARG GLY ARG SEQRES 8 F 169 PHE ALA THR VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL SEQRES 9 F 169 ASN TRP GLY ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY SEQRES 10 F 169 VAL MET CYS VAL GLU SER VAL ASN ARG GLU MET SER PRO SEQRES 11 F 169 LEU VAL ASP ASN ILE ALA LEU TRP MET THR GLU TYR LEU SEQRES 12 F 169 ASN ARG HIS LEU HIS THR TRP ILE GLN ASP ASN GLY GLY SEQRES 13 F 169 TRP ASP ALA PHE VAL GLU LEU TYR GLY PRO SER MET ARG HET 398 A1163 53 HET 398 B1163 53 HET 398 C1163 53 HET 398 D1163 53 HET 398 E1163 53 HET 398 F1163 53 HETNAM 398 N,N-DIBUTYL-4-CHLORANYL-1-[2-(3,4-DIHYDRO-1H- HETNAM 2 398 ISOQUINOLIN-2-YLCARBONYL)-4-[(7- HETNAM 3 398 IODANYLNAPHTHALEN-2-YL)SULFONYLCARBAMOYL]PHENYL]-5-METHYL- HETNAM 4 398 PYRAZOLE-3-CARBOXAMIDE FORMUL 7 398 6(C40 H41 CL I N5 O5 S) HELIX 1 1 ASP A 10 ARG A 26 1 17 HELIX 2 2 VAL A 51 TYR A 67 1 17 HELIX 3 3 TYR A 67 LEU A 78 1 12 HELIX 4 4 THR A 84 PHE A 97 1 14 HELIX 5 5 ASN A 102 ARG A 123 1 22 HELIX 6 6 PRO A 127 LEU A 144 1 18 HELIX 7 7 LEU A 144 ASN A 151 1 8 HELIX 8 8 GLY A 152 GLU A 159 1 8 HELIX 9 9 ASP B 10 ARG B 26 1 17 HELIX 10 10 VAL B 51 TYR B 67 1 17 HELIX 11 11 TYR B 67 LEU B 78 1 12 HELIX 12 12 THR B 84 PHE B 97 1 14 HELIX 13 13 ASN B 102 ARG B 123 1 22 HELIX 14 14 PRO B 127 HIS B 143 1 17 HELIX 15 15 LEU B 144 ASN B 151 1 8 HELIX 16 16 GLY B 152 GLY B 162 1 11 HELIX 17 17 ASP C 10 ARG C 26 1 17 HELIX 18 18 VAL C 51 TYR C 67 1 17 HELIX 19 19 TYR C 67 LEU C 78 1 12 HELIX 20 20 THR C 84 ARG C 98 1 15 HELIX 21 21 ASN C 102 ARG C 123 1 22 HELIX 22 22 PRO C 127 LEU C 144 1 18 HELIX 23 23 LEU C 144 ASN C 151 1 8 HELIX 24 24 GLY C 153 GLY C 162 1 10 HELIX 25 25 ASP D 10 GLN D 25 1 16 HELIX 26 26 GLU D 50 TYR D 67 1 18 HELIX 27 27 TYR D 67 GLN D 77 1 11 HELIX 28 28 THR D 84 PHE D 97 1 14 HELIX 29 29 ASN D 102 ARG D 123 1 22 HELIX 30 30 PRO D 127 LEU D 144 1 18 HELIX 31 31 LEU D 144 ASN D 151 1 8 HELIX 32 32 GLY D 152 LEU D 160 1 9 HELIX 33 33 ASP E 10 ARG E 26 1 17 HELIX 34 34 VAL E 51 TYR E 67 1 17 HELIX 35 35 TYR E 67 GLN E 77 1 11 HELIX 36 36 THR E 84 ARG E 98 1 15 HELIX 37 37 ASN E 102 ARG E 123 1 22 HELIX 38 38 SER E 126 LEU E 144 1 19 HELIX 39 39 LEU E 144 ASN E 151 1 8 HELIX 40 40 GLY E 152 GLY E 162 1 11 HELIX 41 41 ASP F 10 GLN F 25 1 16 HELIX 42 42 GLU F 50 TYR F 67 1 18 HELIX 43 43 TYR F 67 SER F 76 1 10 HELIX 44 44 THR F 84 PHE F 97 1 14 HELIX 45 45 ASN F 102 ARG F 123 1 22 HELIX 46 46 PRO F 127 LEU F 144 1 18 HELIX 47 47 LEU F 144 ASN F 151 1 8 HELIX 48 48 GLY F 152 GLY F 162 1 11 CISPEP 1 TYR F 161 GLY F 162 0 -29.13 SITE 1 AC1 10 TYR A 67 ASP A 70 MET A 74 GLU A 95 SITE 2 AC1 10 LEU A 96 ARG A 105 GLN E 58 LEU E 160 SITE 3 AC1 10 TYR E 161 GLY E 162 SITE 1 AC2 15 PHE B 63 TYR B 67 ASP B 70 PHE B 71 SITE 2 AC2 15 MET B 74 VAL B 92 GLU B 95 GLY B 104 SITE 3 AC2 15 ALA B 108 PHE B 112 TYR B 161 GLN D 58 SITE 4 AC2 15 TYR D 161 GLY D 162 PRO E 82 SITE 1 AC3 11 PHE C 63 TYR C 67 ASP C 70 MET C 74 SITE 2 AC3 11 GLU C 95 LEU C 96 TYR C 161 PRO D 82 SITE 3 AC3 11 GLN F 58 TYR F 161 GLY F 162 SITE 1 AC4 11 PRO A 82 GLN B 58 LEU B 160 TYR B 161 SITE 2 AC4 11 GLY B 162 PHE D 63 TYR D 67 ASP D 70 SITE 3 AC4 11 MET D 74 GLU D 95 ALA D 108 SITE 1 AC5 11 GLN A 58 LEU A 160 TYR A 161 GLY A 162 SITE 2 AC5 11 PHE E 63 TYR E 67 ASP E 70 MET E 74 SITE 3 AC5 11 VAL E 92 GLU E 95 ALA E 108 SITE 1 AC6 11 PHE B 83 GLN C 58 LEU C 160 TYR C 161 SITE 2 AC6 11 GLY C 162 PHE F 63 TYR F 67 ASP F 70 SITE 3 AC6 11 VAL F 92 GLU F 95 ALA F 108 CRYST1 115.214 115.214 102.318 90.00 90.00 120.00 P 32 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008680 0.005011 0.000000 0.00000 SCALE2 0.000000 0.010022 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009773 0.00000 MTRIX1 1 1.000000 0.000000 0.000000 0.00000 1 MTRIX2 1 0.000000 1.000000 0.000000 0.00000 1 MTRIX3 1 0.000000 0.000000 1.000000 0.00000 1 MTRIX1 2 -0.999896 -0.002574 -0.014206 -56.68136 1 MTRIX2 2 0.004890 -0.986189 -0.165554 24.74994 1 MTRIX3 2 -0.013583 -0.165606 0.986098 36.21980 1 MTRIX1 3 -0.501065 0.860651 -0.090629 -0.46102 1 MTRIX2 3 -0.833152 -0.508062 -0.218473 -5.25083 1 MTRIX3 3 -0.234074 -0.033961 0.971625 -1.35637 1 MTRIX1 4 0.998112 -0.011743 0.060290 -0.82415 1 MTRIX2 4 0.011612 0.999929 0.002517 -1.77654 1 MTRIX3 4 -0.060316 -0.001812 0.998178 33.11996 1 MTRIX1 5 -0.999594 -0.006045 0.027859 -59.37437 1 MTRIX2 5 0.002596 -0.992501 -0.122213 28.60782 1 MTRIX3 5 0.028389 -0.122091 0.992113 2.53127 1 MTRIX1 6 0.477377 -0.870284 0.121313 54.98487 1 MTRIX2 6 0.870083 0.487455 0.073092 34.36977 1 MTRIX3 6 -0.122745 0.070660 0.989920 -11.18358 1